IWFS:LSE:LSE-iShares MSCI World Size Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 3437

Change

+45.50 (+1.34)%

Market Cap

USD 0.22B

Volume

33.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+260.00 (+3.54%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

+2.75 (+1.46%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-18.15 (-2.00%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.10%)

USD 617.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 617.54B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-5.75 (-0.28%)

USD 320.04B
0QZK:LSE Coca-Cola Co.

-0.70 (-1.10%)

USD 266.08B
0QZO:LSE 0QZO

-0.10 (-0.09%)

USD 258.54B

ETFs Containing IWFS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.03% 46% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.03% 45% F 51% F
Trailing 12 Months  
Capital Gain 9.90% 59% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.90% 58% F 63% D
Trailing 5 Years  
Capital Gain 31.31% 54% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.31% 52% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.15% 59% D- 64% D
Dividend Return 6.15% 58% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.94% 56% F 71% C-
Risk Adjusted Return 47.56% 65% D 77% C+
Market Capitalization 0.22B 58% F 50% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike